riccd2001
Fri Aug 30, 2013, 09:01 PM
There is a new discussion today in the MDS Beacon regarding a recent small retrospective study by German researchers suggesting that a short course of treatment with the immunosuppressive agent, Campath, may be effective and safe for some patients with lower-risk MDS. :cool:
http://www.mdsbeacon.com/news/2013/08/30/campath-lower-risk-myelodysplastic-syndromes/
http://www.mdsbeacon.com/news/2013/08/30/campath-lower-risk-myelodysplastic-syndromes/